NEJM September 13, 2023
Carter Dredge, MHA and Stefan Scholtes, PhD

The first empirical evidence of the not-for-profit “health care utility” model indicates improved access to commoditized generic drugs at reduced prices for a member health system.

Summary

This article focuses on the value of introducing novel business models into health care to address market failures that are hurting people — delving deeply into learning from real-world examples within the generic drug supply chain and its failure to supply critical medicines reliably at a low cost. Some problems in health care are so complex that traditional private-sector or governmental interventions alone have not been able to solve the problems. In an original response to ongoing generic drug shortages, in 2018, seven U.S. health systems and three philanthropic organizations founded a novel...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Provider, Supply Chain, Technology
Tenet receives $4.8B from 14 hospital sales
Steward completes physician group sale: 4 things to know
Jennie Stuart would get 'expedited' Epic switch with Deaconess merger, officials say
Emory launches Healthcare Test Kitchen Lab
Steward completes sale of physician group: 5 things to know

Share This Article